N@N

PharMerica Announces Renewal of Golden Living Contract

_{//stocks-investing.news-articles.net/content/200 .. announces-renewal-of-golden-living-contract.html}
^{Published in Stocks and Investing on Tuesday, February 17th 2009 at 8:25 GMT, Last Modified on 2009-02-17 08:26:37 by Market Wire}  

LOUISVILLE, Ky.--([ BUSINESS WIRE ])--PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today announced the renewal of its current contract to provide institutional pharmacy services to Golden Living. The new contract is effective for one year with an auto-renewal provision.

In commenting on the contract renewal, Gregory S. Weishar, PharMerica's Chief Executive Officer, said, "Golden Living is a valued client and we are pleased to continue our long-standing partnership with them to provide pharmacy care to the elderly population."

About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company servicing healthcare facilities in the United States. PharMerica operates over 100 institutional pharmacies in 40 states. PharMerica's customers are institutional healthcare providers, such as nursing centers, assisted living facilities, hospitals and other long-term care providers. The Company also provides pharmacy management services to long-term care hospitals.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which reflect the Company's current estimates, expectations and projections about its future results, performance, prospects and opportunities.Forward-looking statements include, among other things, the Company's continued focus on its initiatives of growing our client base, improving client retention and streamlining our operations and billing processes, the information concerning the Company's possible future results of operations, the continued benefits and synergies to be obtained from the Pharmacy Transaction, the Company's ability to purchase acquisition targets, and the strength of the Company's financial performance during 2009.Forward-looking statements include statements that are not historical facts and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "plan," "may," "should," "will," "would," "project" and similar expressions.These forward-looking statements are based upon information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.Important factors that could cause the Company's actual results to differ materially from the results referred to in the forward-looking statements we make in this press release are included in the Risk Factors section set forth in the Company's Annual Report on Form 10-K filed with the SEC and in other reports, including current reports on Form 10-Q, filed with the SEC by the Company.

You are cautioned not to place undue reliance on any forward-looking statements, all of which speak only as of the date of this press release.Except as required by law, we undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect any events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.All subsequent written and oral forward-looking statements attributable to us or any person acting on the Company's behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this press release and in the Risk Factors section set forth in the Company's Annual Report on Form 10-K filed with the SEC and in other reports filed with the SEC by the Company.